| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Shares due for debt conversion affiliates | - | 0 |
| Shares due for debt conversion | - | 8,510 |
| Accounts payable and accrued expenses affiliates | 115,014 | -131,288 |
| Net cash used in operating activities | -289,484 | -248,010 |
| Investment in intangibles | 16,851 | 15,177 |
| Net cash used in investing activities | -16,851 | -15,177 |
| Proceeds from stock sales | - | 0 |
| Stock subscription for cash | 13,353 | - |
| Short-term loans | 2,000 | 0 |
| Proceeds from issuance of convertible notes payable | - | 0 |
| Short-term loans from affiliates | 300,327 | 261,177 |
| Net cash provided by financing activities | 315,680 | 261,177 |
| Net decrease in cash | 9,345 | -2,010 |
| Cash and cash equivalents at beginning of period | 5,154 | - |
| Cash and cash equivalents at end of period | 14,499 | - |
BIOXYTRAN, INC (BIXT)
BIOXYTRAN, INC (BIXT)